spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for pharmaceutical and medical device applications

Novo Nordisk Pharmatech A/S


Novo Nordisk Pharmatech A/S has entered into an agreement with Signet Chemical Corporation Pvt. Ltd. for the distribution of their pharmaceutical range of quaternary ammonium compounds (FEF® Quats) to the healthcare industry in India, Bangladesh and Sri Lanka.

Mr. Harish Shah – managing director of Signet commented on this new collaboration: “We are pleased to be associated with Novo Nordisk Pharmatech which is the leading supplier of Quats to the pharmaceutical and biopharmaceutical markets. Novo Nordisk Pharmatech’s FeF® Quats complement our existing portfolio of excipients used especially for ophthalmic, nasal and topical dosage forms”.

Novo Nordisk Pharmatech A/S manufactures Quats (Benzalkonium Chloride, Cetrimide and Cetyl Trimethyl Ammonium Bromide (CTAB), including customised grade, in accordance with cGMP (ICH Q7) for active pharmaceutical ingredients which is the highest available quality standard. Their products comply with the latest pharmacopoeial standards and are extensively supported by CEPs, DMFs and a comprehensive package of regulatory and quality assurance documents. Their manufacturing site (Koege, Denmark) is audited by the Danish Medicines Agency and US FDA.

“We are very happy to work with Signet as our distribution partner for pharmaceuticals. Novo Nordisk Pharmatech’s FeF® Quats products fit perfectly with Signet’s wide range of excipients enabling the customers to take advantage of these synergies. We wish to give the best service to our customers and the local pharma team of Signet are experts in working with customers to support their product development” says Steve Profit, sales & marketing director at Novo Nordisk Pharmatech A/S.

About Signet
Signet, is India’s leading pharmaceutical excipient distributor company offering a broad range of excipients under one crest. Founded in 1986, Signet Chemical Corporation Pvt. Ltd. is a pioneer in the excipients business in India. Since its inception, Signet has combined technical expertise with commercial support to provide its clients accurate information and exceptional product value. With 95 qualified and well-trained members, the Signet team has an excellent understanding of the intricacies of the market and has strong relationships with key partners to take the company forward. Signet has a turnover of approx. 174 million US dollars with around 100 employees serving India, Bangladesh, Nepal and Sri Lanka.

About Novo Nordisk Pharmatech A/S
Novo Nordisk Pharmatech A/S was established in 1949 as FeF Chemicals, acquired by Novo Nordisk in 1986 and has been part of the pharmaceutical group since then. It is the leading worldwide supplier of recombinant insulin for cell growth media and pharmaceutical grade quaternary ammonium compounds (Quats) for the pharmaceutical, biopharmaceutical and personal care industries.

For more information, please visit: www.novonordiskpharmatech.com.
phone +45 5667 1000
email nnprinfo@novonordiskpharmatech.com
web www.novonordiskpharmatech.com
email Koebenhavnsvej 216, 4600 Koege
 
Print this page
Send to a friend
   
spacer
News and Press Releases

BioIVT Webinar Will Discuss How to Optimize Microbiome Research

BioIVT, a leading provider of research models and services for drug development, today announced that it is hosting a webinar entitled “The Microbiome: Understanding Why Collection and Processing Matters” at 11 a.m. ET on July 25.
More info >>


White Papers

Quality By Design

Biopharma Group

Quality by Design (QbD) is a systematic approach to development that begins with the defined objectives and emphasizes science and quality risk management in order to achieve those goals. QbD ensures that the quality of the product is built into production processes from the outset, rather than being tested after development has already commenced.
More info >>

Industry Events

Outsourcing Clinical Trials Nordics 2018

30-31 October 2018, Copenhagen, Denmark

Following on from the success of the 2017 Outsourcing in Clinical Trials Nordics conference, Arena International is pleased to announce that the event will return for its 6th year in 2018. The 2018 event welcomes biopharmaceutical and medical device companies from across the Nordic region to share knowledge and challenges of outsourcing and clinical operations.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement